Member Info for NFTs

The issue they got is the Lanstead deal used all the allotted fundraising this year without having to go to vote again. I am sure they would raise if it was a bit easier but now they will probably wait till Next financial year being April.
The issue I have with this is it’s a pressure timetable!
You either guarantee a deal before which in current situation is a massive ask or you walk the company and SP towards the cliff!
It’s that mindset that is worrying here. Nobody’s fault but Riddel and Anne implementation of this deal has left a backfire legacy to handle.
Right man in the job now and he may well just do it, but risky indeed.

“88,000,000 Ordinary Shares (the "Second Subscription Shares") for gross proceeds of £1,320,000 and the associated 5,700,000 Second Value Payment Shares.”

Quick share vote now to raise say £750,000 plus costs and we move on with another guaranteed year in pocket and probably some more testing on NXP002 plus hopefully a deal!

30 to 40% dilution but for 10 or 20 plus multiples in a deal.

I honestly don’t mind placing and raising funds if it secured a goal which is why they raised December 2019 but then the wrong management took control. Here we are!

I’m still very confident Soup I just want them to get the cash in bank up a little to reduce the anxiety lol

I’m not saying they won’t do it much higher but knowing the company and it’s positioning it would be prudent to get some security in financial gas!!!!
Waiting on these small spec companies with fumes in the pot generally eats at moral and market sentiment causing decline.
It’s really obvious here right now!

The problem here is funding. Nothing really coming in but time rapidly moving ahead and the goal keeps getting pushed fwd. Realistically now at the earliest they will be ready is Spring to try find early partners. The Lanstead gives them few grand to keep the consultants and directors salaries ticking till Sept then that’s it. Empty pot!
Catch 22 here at min. They need a deal and they have the finances to complete these early tests but nothing else. Even I can see a raise now would be prudent and understanding before it’s too late.

Absolutely

Holding large

No

They bought 100,000’s of equipment and materials ahead to cover operations to reduce the high cost impacts. Therefore that don’t need anywhere near as much money as they purchased stockpile which was included in those account figures. This seriously distorted expenditures and this is now there prime period for revenue incomes with significantly larger field with US growing fast and now the high end area in Macau gambling district China which is a bigggg earner.
Obviously not the easiest current market conditions but they are expanding rapidly not maintaining market. It is growing exponentially now. They just need to secure the bottling locally in US and other areas!!

Thanks Graham what unicorn you on now? Or you run out of cash?

See my post saying Graham got removed. Lets just say that must be true then!!! Caught ya

Mulder spend much time up in Aberdeen?????? ;)

You said the same things Moulder (Pettycash) prior to NXP001 test results in early March 2019 when SP dropped to 1.9p they then passed the clinical trials and reported 31st May 2019 and SP hit 15p you then only came back as it drifted down but you were 100% wrong and you completely missed the rise becoming increasingly bitter and twisted. You have since been through at least 6 different names in that time and returned to try attack. You missed it get over it.
You will miss it again lol
What a life you have!!! You are definitely special.

I’m sure some must still love you Pettycash after all those years writing drivel for local paper! God love a trier doesn’t he? :) I’m sure mr handy keeps you happy!

https://en.m.wikipedia.org/wiki/Investigational_New_Drug

https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application

I completely agree that prior to setup on Phase 1 more studies are required and this is standard practice.
Whoever takes on this role with NFX will complete this part so they it’s setup in the manner they wish. That’s been the same with NXP001 when NSB was going to take it fwd to phase 1.
“Investigational New Drug Application enabling studies”
This however is not part of the package that is being presented for JV partnership here. Unless they choose to go alone!
So I’m our case next studies are final

Well “might be a while” it depends on what people feel that timespan is?
In pharmaceutical terms till the end of 2022 is like tomorrow in timescales. So I’m very chuffed with news plans and time expectations. News due apparently on NXP004 he said and over these next couple of months updates on the Human studies for NXP002 to complete the final part required to get this then to Phase 1 start. This being the period as he said where they are talking to parties interested new from discussions at ERS etc and old. I take the old discussions as US and Asia areas as before.
Funded for all this so ready for those updates to keep coming.

Why would you think Kissei would not be interested in their own drug? They would be precisely the first partner we should ask to develop this for then delivery to market or other interested parties imo.

In a different market this could of been a completely different day.
Certainly don’t agree with market reaction but the main points are.
More news due on fast rapid progress on testing on NXP002 this year.
NXP004 update inbound
JV discussions for potential partner
Data and response is clear that significant value and speed is via the combined effect and a necessity to get this into market.
Very attractive play once this becomes realised.
Funded till next phase. Lanstead maybe loved for the deal but it is producing valuable revenue to get this now to a potential deal. A deal is huge in value here. That’s what we wanted to know and that is where we look to be heading!!
Nuformix is very much alive and the current SP is ludicrous

Average was around 20 to 25mil and we are much further with NXP004 and NXP002.
SP currently now should be a minimum of 2.5 to 4.5p without news. So further progress and it should be higher than that as next stop would be deal. That then be 10’s plus easy depending on the size of the deal. Lets just get the recovery going on next hopefully good news hey!

What was our MCAP average in 2019?

Now that’s what I call a good Bun out of the oven especially good batches!